1) differentiation therapy
诱导分化治疗
1.
Aim To determine the application of phenylbutyrate to differentiation therapy of hematological malignancies.
目的探讨苯丁酸钠在血液肿瘤诱导分化治疗中的应用方法。
2) induction therapy
诱导治疗
1.
Effect of Simulect and OKT3induction therapy in renal transplantation;
Simulect和OKT3诱导治疗应用于肾移植临床的疗效比较(英文)
2.
[Objective] To evaluate the efficacy of tacrolimus as the induction therapy in the patients with lupus nephritis (LN).
【目的】前瞻性比较观察他克莫司(FK506)与传统疗法环磷酰胺(CTX)静脉冲击联合激素诱导治疗狼疮性肾炎(LN)的临床疗效。
3.
Methodology:Ninety-two cases of biopsy proved LN,including class Ⅳ,Ⅳ+Ⅴ,Ⅲ+Ⅴ or Ⅴ(according to ISN/RPS 2003 classification criteria) were randomly assigned to either multi-target therapy group [n=62,induction therapy was FK506(3-4 mg/d) and MMF(0.
主要评价指标为诱导治疗期完全缓解率(CR,定义为尿蛋白定量<0。
3) induced treatment
诱导治疗
1.
As a hidden rule which facilitate hospitals and its medical staff to seek exorbitant profits,"induced treatment"has been prevalent in China for years.
医生诱导治疗已逐渐成为当前医院及其医务人员谋求暴利的潜规则。
4) Induction chemotherapy
诱导化疗
1.
Induction chemotherapy combined with concurrent chemotherapy and radiotherapy in the treatment of stage Ⅲ non-small cell lung cancer;
诱导化疗配合同期放化疗治疗Ⅲ期非小细胞肺癌
2.
Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma
诱导化疗后局部晚期鼻咽癌调强放疗肿瘤靶区勾画方式改变对剂量分布和临床疗效的影响
3.
Results The overall response rates of induction chemotherapy with radiotherapy(CT/RT) group and radiotherapy(RT) group we.
目的研究紫杉醇加顺铂方案诱导化疗(TP)治疗晚期鼻咽癌的临床疗效。
6) neoadjuvant chemotherapy
诱导化疗
1.
Impact of neoadjuvant chemotherapy on proliferative of tumor cells in tongue squamous cell carcinoma.;
诱导化疗对舌鳞癌肿瘤细胞增殖的影响
2.
Response to neoadjuvant chemotherapy as a good prognostic parameter;
术前诱导化疗在头颈部肿瘤预后评价中的意义
补充资料：诱导癌细胞分化治疗
诱导癌细胞分化治疗
differentiation therapy of cancer cell induced
经研究表明某些恶性疾病，如白血病、胚胎瘤、鳞状细胞癌及神经母细胞瘤等，可被化学物质诱导分化成正常细胞或近似正常细胞，许多肿瘤细胞能被激素、维生素、某些小剂量细胞毒药物、生长因子等诱导而产生分化。目前已有若干种分化诱导剂进入临床Ⅰ、Ⅱ期试验，例如新维甲类化合物维胺酸栓剂，可阻断宫颈癌前病变的发展；全反式维甲酸单独使用能缓解急性早幼粒细胞白血病。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条